0000950170-24-067324.txt : 20240531 0000950170-24-067324.hdr.sgml : 20240531 20240531161505 ACCESSION NUMBER: 0000950170-24-067324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240530 FILED AS OF DATE: 20240531 DATE AS OF CHANGE: 20240531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greene John CENTRAL INDEX KEY: 0001610732 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 241009863 MAIL ADDRESS: STREET 1: 51 LIME STREET CITY: LONDON STATE: X0 ZIP: EC3M 7DQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 ownership.xml 4 X0508 4 2024-05-30 0001674416 CRISPR Therapeutics AG CRSP 0001610732 Greene John C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET BOSTON MA 02127 true false false false false Stock Option (Right to Buy) 54.06 2024-05-30 4 A false 13000 0 A 2034-05-30 Common Shares 13000 13000 D This option was granted on May 30, 2024 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on May 31, 2024; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders. /s/ AJ Silver, attorney-in-fact 2024-05-31